* Data collected
08/23/09 - 08/30/09 |
|
|
|
| Investor Relations > FAQ's| 1. | Where do Quest Diagnostics shares of stock, bonds and options trade? | | | Shares in Quest Diagnostics trade on the New York Stock Exchange under the symbol "DGX."
Fixed Income bonds trade over the counter.
Options on DGX shares are traded on the Chicago Board Options Exchange.
|
| 2. | Who is Quest Diagnostics’ transfer agent? | | | Our transfer agent is Computershare. They can be reached at:
Computershare
P.O. Box 43078
Providence, RI 02940
Telephone inquiries: 800-622-6757 (US, Canada, Puerto Rico)
781-575-4735 (all other locations)
Internet inquiries:
Investor Centre website at www.computershare.com/investor
Address changes should be reported to Computershare.
|
| 3. | What is book-entry and how do I keep track of my book-entry shares? | | | Book-entry form of registered ownership allows you to own shares without having paper stock certificates in your possession. You are the record owner and enjoy the same shareholder benefits as you would with certificated shares. If you have book-entry shares, you will receive a statement of your holdings on a yearly basis. You may, of course, request an additional statement at any time by contacting Computershare at 800-622-6757 (US, Canada, Puerto Rico) or 781-575-4735 (all other locations). |
| 4. | What is Quest Diagnostics’ dividend policy? | | | Quest Diagnostics pays a quarterly dividend of $0.10 per share.
You may elect to have your dividend directly deposited to your personal checking or saving account by completing the Direct Deposit Plan Enrollment.
You may elect to have your dividend reinvesting in Quest Diagnostics stock by enrolling in The Quest Diagnostics Dividend Reinvestment Plan.
|
| 5. | What is the next dividend payment date? | | |
The next dividend payment date is October 19, 2009 for shareholders of record as of October 2, 2009.
The dividend payment information for the four preceding quarters is as follows:
| Record Date |
July 6, 2009 |
April 6, 2009 |
January 9, 2009 |
October 3, 2008 |
| Payment Date |
July 18, 2009 |
April 20, 2009 |
January 26, 2009 |
October 20, 2008 |
| Dividend Payment |
$0.10
|
$0.10
|
$0.10
|
$0.10
|
|
| 6. | What is the Company's stock-split history? | | | Quest Diagnostics executed two-for-one stock splits on May 31, 2001 and on June 20, 2005.
|
| 7. | Does Quest Diagnostics have a direct purchase plan? | | | No. Quest Diagnostics does not have a direct purchase plan and does not have plans to implement one.
|
| 8. | What are Quest Diagnostics' credit ratings?
| | | Quest Diagnostics has credit rating relationships with Standard & Poor's, Moody's Investors Service and Fitch Ratings. Standard & Poor's rating is BBB+ with a stable outlook. Our Moody's current credit rating is Baa3 with a positive outlook. Our current credit rating with Fitch is BBB+ with a stable outlook.
|
| 9. | When will you release your next quarterly results? | | | Quest Diagnostics will release financial results for the third quarter ended September 30, 2009, before the stock market opens on October 20, 2009. |
| 10. | How many shares does GlaxoSmithKline own? | | | GlaxoSmithKline holds approximately 30.8 million shares, or 16.5% of the outstanding shares of Quest Diagnostics. |
| 11. | Does GlaxoSmithKline have representation on the Quest Diagnostics board of directors? | | | As part of the transaction, GlaxoSmithKline has the right to designate one member on the Quest Diagnostics Board of Directors and has agreed to certain standstill provisions in connection with its ownership of Quest Diagnostics common stock. |
|
